Insider Trading History of Albers Jeffrey W.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Albers Jeffrey W. since year 2005. The trader's CIK number is 1638474. At the time of the last reporting, Albers Jeffrey W. was the CEO and President of Blueprint Medicines Corp . (stock ticker symbol BPMC). See this page for all insider trading activities at Blueprint Medicines Corp .


Stock purchases, sales, and option exercises reported by insider Albers Jeffrey W. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-11-18 BPMC Blueprint Medicines Corp Option Ex 20,000 5.33 106,700
2019-11-18 BPMC Blueprint Medicines Corp Sale 8,256 75.76 625,474
2019-11-08 BPMC Blueprint Medicines Corp Sale 11,744 74.56 875,632
2019-10-30 BPMC Blueprint Medicines Corp Option Ex 20,000 1.87 37,400
2019-08-19 BPMC Blueprint Medicines Corp Sale 20,000 83.24 1,664,800
2019-08-19 BPMC Blueprint Medicines Corp Option Ex 20,000 1.87 37,400
2019-06-17 BPMC Blueprint Medicines Corp Option Ex 5,000 1.87 9,350
2019-06-17 BPMC Blueprint Medicines Corp Sale 5,000 99.06 495,300
2019-06-12 BPMC Blueprint Medicines Corp Sale 20,000 84.13 1,682,560
2019-06-12 BPMC Blueprint Medicines Corp Option Ex 20,000 1.87 37,400
2019-03-15 BPMC Blueprint Medicines Corp Option Ex 20,000 1.87 37,400
2019-03-15 BPMC Blueprint Medicines Corp Sale 20,000 86.49 1,729,740
2018-11-19 BPMC Blueprint Medicines Corp Option Ex 28,961 1.87 54,157
2018-11-05 BPMC Blueprint Medicines Corp Option Ex 20,000 1.87 37,400
2018-11-05 BPMC Blueprint Medicines Corp Sale 20,000 63.92 1,278,360
2018-08-06 BPMC Blueprint Medicines Corp Sale 20,000 69.95 1,399,100
2018-08-06 BPMC Blueprint Medicines Corp Option Ex 20,000 1.87 37,400
2018-05-07 BPMC Blueprint Medicines Corp Option Ex 20,000 1.87 37,400
2018-05-07 BPMC Blueprint Medicines Corp Sale 20,000 78.86 1,577,100
2018-03-02 BPMC Blueprint Medicines Corp Option Ex 20,000 1.87 37,400
2018-03-02 BPMC Blueprint Medicines Corp Sale 20,000 91.55 1,831,020
2017-11-06 BPMC Blueprint Medicines Corp Sale 30,000 71.26 2,137,800
2017-11-06 BPMC Blueprint Medicines Corp Option Ex 24,514 1.87 45,841
2017-08-08 BPMC Blueprint Medicines Corp Sale 10,000 50.70 507,000
2017-08-07 BPMC Blueprint Medicines Corp Sale 20,000 48.75 975,000
2017-06-28 BPMC Blueprint Medicines Corp Sale 20,000 50.18 1,003,540
2017-03-14 BPMC Blueprint Medicines Corp Sale 20,000 39.90 797,900
2016-08-08 BPMC Blueprint Medicines Corp Sale 17,000 23.03 391,510
2016-06-03 BPMC Blueprint Medicines Corp Sale 17,000 20.03 340,510
2016-04-06 BPMC Blueprint Medicines Corp Sale 17,000 20.42 347,140
2015-11-10 BPMC Blueprint Medicines Corp Sale 7,000 21.87 153,090
2015-11-02 BPMC Blueprint Medicines Corp Sale 10,000 21.02 210,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Albers Jeffrey W. (CEO and President of Blueprint Medicines Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month